Medopad is a global leader in enterprise mobile health solutions that enables healthcare without boundaries by uniting doctors and patients using mobile devices and wearables. The Medopad platform can bring together multiple medical databases, sensors in wearables and apps to capture patient data. As a result, the doctor can make informed decisions based on real time data. At the same time, patients become part of improving their own health through higher engagement and enhanced conversation with their doctor. The result is an improved quality of care with lower operating costs. Medopad is a regulatory approved and award-winning solution. Medopad has been CE mark approved as a medical device, FDA registered, and is HIPAA compliant.
London, GB
Size (employees)
57 (est)+19%
Medopad was founded in 2001 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Medopad

Rich Khatib

Rich Khatib

Chief Executive Officer and Co-Founder
Dan Vahdat

Dan Vahdat

Chief Technology Officer and Co-Founder

Medopad Office Locations

Medopad has offices in München, Singapore and London
London, GB (HQ)
78 Buckingham Gate
München, DE
69 Ungererstraße
Singapore, SG
1 Fusionopolis Way
Show all (3)
Report incorrect company information

Medopad Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$32 m

Latest funding size

$28 m

Time since last funding

4 months ago


Medopad's latest funding round in February 2018 was reported to be $28 m. In total, Medopad has raised $32 m
Show all financial metrics

Medopad Financials

Cash (30-Nov-2016)

1.1 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016


33.5 k524.5 k351.2 k1.1 m

Accounts Receivable

844 927 3.3 k2.6 k

Current Assets

34.3 k525.4 k354.5 k1.1 m


4.1 k9 k10.6 k19.7 k
Y, 2016

Financial Leverage

1 x
Show all financial metrics
Report incorrect company information

Medopad News and Updates

Health tech AI company Medopad attracts $28 mln

UK-based Medopad, a health tech AI company, has raised $28 million in funding. The investors included China’s NWS Holdings. UBS Limited was financial adviser to Medopad on the transaction.

Health tech startup Medopad raises $28 million from Chinese investors

UK digital health startup Medopad has announced $28 million in funding led by China’s NWS Holdings, with a view to raising $120 million in total for the Series A round. Medopad is a platform for data capture and improving communication between patients and healthcare professionals. Powered by AI and…
Report incorrect company information